Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD.

Autor: Pippis EJ; Gilead Sciences, Inc. Medical Affairs, Foster City, CA, USA., Yacyshyn BR; Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.

Publikováno v: Inflammatory bowel diseases [Inflamm Bowel Dis] 2021 Oct 18; Vol. 27 (10), pp. 1674-1683.